Efficiacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study. - Yao,J.C.; Phan,A.T.; Chang,D.Z. (J Clin Oncol, 2008)